These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10201821)

  • 21. Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases.
    Salituro FG; Germann UA; Wilson KP; Bemis GW; Fox T; Su MS
    Curr Med Chem; 1999 Sep; 6(9):807-23. PubMed ID: 10495353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages.
    Chen CC; Wang JK
    Mol Pharmacol; 1999 Mar; 55(3):481-8. PubMed ID: 10051531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SAR of 4-hydroxypiperidine and hydroxyalkyl substituted heterocycles as novel p38 map kinase inhibitors.
    Revesz L; Di Padova FE; Buhl T; Feifel R; Gram H; Hiestand P; Manning U; Zimmerlin AG
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1261-4. PubMed ID: 10866395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour necrosis factor-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils.
    Waterman WH; Molski TF; Huang CK; Adams JL; Sha'afi RI
    Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):17-20. PubMed ID: 8870643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function.
    Badger AM; Bradbeer JN; Votta B; Lee JC; Adams JL; Griswold DE
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1453-61. PubMed ID: 8968371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes.
    Laufer SA; Wagner GK; Kotschenreuther DA; Albrecht W
    J Med Chem; 2003 Jul; 46(15):3230-44. PubMed ID: 12852754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck II.
    Burchat AF; Calderwood DJ; Hirst GC; Holman NJ; Johnston DN; Munschauer R; Rafferty P; Tometzki GB
    Bioorg Med Chem Lett; 2000 Oct; 10(19):2171-4. PubMed ID: 11012022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of p38 mitogen-activated protein kinase in heat shock protein 27 induction in human neutrophils.
    Niwa M; Hotta K; Kanamori Y; Hatakeyama D; Hirade K; Katayama M; Hara A; Mori H; Ito H; Kato K; Matsuno H; Uematsu T; Kozawa O
    Eur J Pharmacol; 2003 Apr; 466(3):245-53. PubMed ID: 12694807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of rat hepatocyte proliferation by transforming growth factor beta and glucagon is associated with inhibition of ERK2 and p70 S6 kinase.
    Dixon M; Agius L; Yeaman SJ; Day CP
    Hepatology; 1999 May; 29(5):1418-24. PubMed ID: 10216124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SB 203580, an inhibitor of p38 mitogen-activated protein kinase, enhances constitutive apoptosis of cytokine-deprived human eosinophils.
    Kankaanranta H; De Souza PM; Barnes PJ; Salmon M; Giembycz MA; Lindsay MA
    J Pharmacol Exp Ther; 1999 Aug; 290(2):621-8. PubMed ID: 10411570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of regioisomers in a series of N-substituted pyridin-4-yl imidazole derivatives by regiospecific synthesis, GC/MS, and 1H NMR.
    Wagner GK; Kotschenreuther D; Zimmermann W; Laufer SA
    J Org Chem; 2003 May; 68(11):4527-30. PubMed ID: 12762762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs).
    Clerk A; Sugden PH
    FEBS Lett; 1998 Apr; 426(1):93-6. PubMed ID: 9598985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580.
    Eyers PA; van den IJssel P; Quinlan RA; Goedert M; Cohen P
    FEBS Lett; 1999 May; 451(2):191-6. PubMed ID: 10371163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and SAR studies of diarylpyrrole anticoccidial agents.
    Qian X; Liang GB; Feng D; Fisher M; Crumley T; Rattray S; Dulski PM; Gurnett A; Leavitt PS; Liberator PA; Misura AS; Samaras S; Tamas T; Schmatz DM; Wyvratt M; Biftu T
    Bioorg Med Chem Lett; 2006 May; 16(10):2817-21. PubMed ID: 16517161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of the p38 mitogen-activated kinase modulate IL-4 induction of low affinity IgE receptor (CD23) in human monocytes.
    Marshall LA; Hansbury MJ; Bolognese BJ; Gum RJ; Young PR; Mayer RJ
    J Immunol; 1998 Dec; 161(11):6005-13. PubMed ID: 9834082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes.
    Manthey CL; Wang SW; Kinney SD; Yao Z
    J Leukoc Biol; 1998 Sep; 64(3):409-17. PubMed ID: 9738669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of protein kinase C, p38 MAP kinase and ERK in arachidonic acid-stimulated superoxide production in human neutrophils.
    Hii CS; Huang ZH; Bilney A; Stacey K; Murray AW; Rathjen DA; Ferrante A
    Adv Exp Med Biol; 1999; 469():365-70. PubMed ID: 10667354
    [No Abstract]   [Full Text] [Related]  

  • 38. The P38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1beta on long-term potentiation in the rat dentate gyrus in vitro.
    Coogan AN; O'Neill LA; O'Connor JJ
    Neuroscience; 1999; 93(1):57-69. PubMed ID: 10430470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct roles for p42/p44 and p38 mitogen-activated protein kinases in the induction of IL-2 by IL-1.
    Matthews JS; O'Neill LA
    Cytokine; 1999 Sep; 11(9):643-55. PubMed ID: 10479400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase.
    Trejo A; Arzeno H; Browner M; Chanda S; Cheng S; Comer DD; Dalrymple SA; Dunten P; Lafargue J; Lovejoy B; Freire-Moar J; Lim J; Mcintosh J; Miller J; Papp E; Reuter D; Roberts R; Sanpablo F; Saunders J; Song K; Villasenor A; Warren SD; Welch M; Weller P; Whiteley PE; Zeng L; Goldstein DM
    J Med Chem; 2003 Oct; 46(22):4702-13. PubMed ID: 14561090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.